FDA Approval and Priority Review in Ovarian Cancer, End of Part B Payment Model, and More

Gina Columbus

Gina Columbus reports on an FDA approval and a priority review in ovarian cancer, 2 CHMP recommendations in non–small cell lung cancer, disappointing results in a prostate cancer trial, a co-branding partnership between 2 institutions, and the official demise of the Part B Payment Model.
Printer Printing...